Global Antipsychotic Drugs Market to reach USD 14.5 billion by 2027.

Global Antipsychotic Drugs Market Size study, Antipsychotic Drugs Market by Drug Class (First Generation, Second Generation, Third Generation and Others), by Application (Schizophrenia, Dementia, Bipolar and Unipolar Depression) and Regional Forecasts 2021-2027
Product Code:  HALDAT_27289189
 Chapter 1.	Executive Summary 
1.1.	Market Snapshot
1.2.	Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1.	Antipsychotic Drugs Market, by Drug Class, 2019-2027 (USD Billion)
1.2.2.	Antipsychotic Drugs Market, by Application, 2019-2027 (USD Billion)
1.3.	Key Trends
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	Global Antipsychotic Drugs Market Definition and Scope 
2.1.	Objective of the Study
2.2.	Market Definition & Scope
2.2.1.	Scope of the Study
2.2.2.	Industry Evolution
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	Global Antipsychotic Drugs Market Dynamics	
3.1.	Antipsychotic Drugs Market Impact Analysis (2019-2027)
3.1.1.	Market Drivers
3.1.1.1.	Increased cases of psychotic disorders
3.1.1.2.	Increased awareness for mental health and well-being
3.1.2.	Market Challenges
3.1.2.1.	Stigma attached to mental health disorders
3.1.3.	Market Opportunities
3.1.3.1.	Governmental support to raise awareness for treatment
Chapter 4.	Global Antipsychotic Drugs Market Industry Analysis
4.1.	Porter’s 5 Force Model
4.1.1.	Bargaining Power of Suppliers
4.1.2.	Bargaining Power of Buyers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2.	PEST Analysis
4.2.1.	Political 
4.2.2.	Economical
4.2.3.	Social 
4.2.4.	Technological 
4.3.	Investment Adoption Model
4.4.	Analyst Recommendation & Conclusion
Chapter 5.	Global Antipsychotic Drugs Market, by Drug Class
5.1.	Market Snapshot 
5.2.	Global Antipsychotic Drugs Market by Drug Class, Performance - Potential Analysis
5.3.	Global Antipsychotic Drugs Market Estimates & Forecasts by Drug Class 2018-2027 (USD Billion)
5.4.	Antipsychotic Drugs Market, Sub Segment Analysis
5.4.1.	First Generation/Standard/Typical Antipsychotics Drug
5.4.2.	Second Generation/Atypical Antipsychotics Drug
5.4.3.	Third generation Antipsychotics Drug
5.4.4.	Other market
Chapter 6.	Global Antipsychotic Drugs Market, by Application
6.1.	Market Snapshot 
6.2.	Global Antipsychotic Drugs Market by Application, Performance - Potential Analysis
6.3.	Global Antipsychotic Drugs Market Estimates & Forecasts by Application 2018-2027 (USD Billion)
6.4.	Antipsychotic Drugs Market, Sub Segment Analysis
6.4.1.	Schizophrenia
6.4.2.	Bipolar Disorder
6.4.3.	Depression
6.4.4.	Dementia
6.4.5.	Other psychotic disorders
Chapter 7.	Global Antipsychotic Drugs Market, Regional Analysis
7.1.	Antipsychotic Drugs Market, Regional Market Snapshot 
7.2.	North America Antipsychotic Drugs Market 
7.2.1.	U.S. Antipsychotic Drugs Market
7.2.1.1.	Drug Class breakdown estimates & forecasts, 2018-2027 
7.2.1.2.	Application breakdown estimates & forecasts, 2018-2027
7.2.2.	Canada Antipsychotic Drugs Market
7.3.	Europe Antipsychotic Drugs Market Snapshot
7.3.1.	U.K. Antipsychotic Drugs Market 
7.3.2.	Germany Antipsychotic Drugs Market
7.3.3.	France Antipsychotic Drugs Market
7.3.4.	Spain Antipsychotic Drugs Market
7.3.5.	Italy Antipsychotic Drugs Market
7.3.6.	Rest of Europe Antipsychotic Drugs Market
7.4.	Asia-Pacific Antipsychotic Drugs Market Snapshot
7.4.1.	China Antipsychotic Drugs Market 
7.4.2.	India Antipsychotic Drugs Market 
7.4.3.	Japan Antipsychotic Drugs Market
7.4.4.	Australia Antipsychotic Drugs Market
7.4.5.	South Korea Antipsychotic Drugs Market
7.4.6.	Rest of Asia Pacific Antipsychotic Drugs Market
7.5.	Latin America Antipsychotic Drugs Market Snapshot
7.5.1.	Brazil Antipsychotic Drugs Market
7.5.2.	Mexico Antipsychotic Drugs Market
7.6.	Rest of The World Antipsychotic Drugs Market
Chapter 8.	Competitive Intelligence
8.1.	Top Market Strategies
8.2.	Company Profiles
8.2.1.	 Johnson & Johnson
8.2.1.1.	Key Information
8.2.1.2.	Overview
8.2.1.3.	Financial (Subject to Data Availability)
8.2.1.4.	Product Summary
8.2.1.5.	Recent Developments
8.2.2.	  Pfizer, Inc.
8.2.3.	 Eli Lilly & Co.
8.2.4.	 Bristol-Myers Squibb Company
8.2.5.	 AstraZeneca
8.2.6.	 Glaxo SmithKline, Plc
8.2.7.	 Allergan
8.2.8.	 Otsuka Pharmaceutical Co., Ltd.
8.2.9.	 Sumitomo Dainippon Pharma Co., Ltd.
8.2.10.	Vanda Pharmaceuticals Inc.
Chapter 9.	Research Process
9.1.	Research Process
9.1.1.	Data Mining
9.1.2.	Analysis
9.1.3.	Market Estimation
9.1.4.	Validation
9.1.5.	Publishing
9.2.	Research Attributes
9.3.	Research Assumption

Global Antipsychotic Drugs Market is valued approximately USD 12.67 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 1.95% over the forecast period 2021-2027. A “psychotic disorder” is an umbrella term to describe multiple types of mental health conditions that involve a phenomenon called psychosis. The word ‘psychosis’ is used to describe conditions that affect the mind, where there has been some loss of contact with reality. It can be caused by some medications, alcohol or drug abuse. Schizophrenia, a common type, has patients often experiencing delusions or hallucinations. Antipsychotic drugs, also called tranquilizers, are prescribed to treat schizophrenia and to reduce the symptoms of bipolar and other disorders. With the growing cases of psychotic disorders such as bipolar, delusions etc. as well as continuous innovations in research of antipsychotic drugs are driving the growth of Antipsychotic Drugs market. According to World Health Organization, Schizophrenia affects 20 million people globally and usually starts earlier among men. In 2019, almost 69% of people with schizophrenia are not receiving suitable care. In 2019, 90% of people with untreated schizophrenia live in low- and middle- income countries. Also, lack of access to mental health services is an important issue. Stigma, discrimination and violation of human rights of people with psychotic disorders is common and people doesn’t incline to seek help. This may act as a restraint for its growth. However, increasing efforts from government to raise awareness for the treatment and acceptance of psychotic disorder patients may act as an opportunity for Antipsychotic Drugs Market in subsequent decade.

Key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World are analysed to provide a holistic picture of Antipsychotic Drugs Market. Due to greater awareness for mental health issues and disorders as well as higher per capita income, North America has emerged as the significant region across the world in terms of market share. Whereas, Asia-Pacific is expected to exhibit highest growth rate for the forecast period 2021-2027 increasing cases of bipolar and schizophrenic disorders and thus increased demand for antipsychotic drugs. Rising disposable income and growing awareness for mental health issues treatment will also boost growth in this region.

Major market player included in this report are:
Johnson & Johnson
Pfizer, Inc.
Eli Lilly & Co.
Bristol-Myers Squibb Company
AstraZeneca
Glaxo SmithKline, Plc
Allergan
Otsuka Pharmaceutical Co., Ltd.
Sumitomo Dainippon Pharma Co., Ltd.
Vanda Pharmaceuticals Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug Class:
First Generation/Standard/Typical Antipsychotics Drug
Second Generation/Atypical Antipsychotics Drug
Third generation Antipsychotics Drug
Other market

By Application:
Schizophrenia
Bipolar Disorder
Depression
Dementia
Other psychotic disorders

By Region:
North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027

Target Audience of the Global Antipsychotic Drugs Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.



Loading…